The estimated Net Worth of Maura Fitzpatrick is at least 15.5 千$ dollars as of 1 February 2023. Ms Fitzpatrick owns over 4,427 units of 908 Devices stock worth over 15,450$ and over the last 2 years she sold MASS stock worth over 0$.
Ms has made over 1 trades of the 908 Devices stock since 2023, according to the Form 4 filled with the SEC. Most recently she exercised 4,427 units of MASS stock worth 15,450$ on 1 February 2023.
The largest trade she's ever made was exercising 4,427 units of 908 Devices stock on 1 February 2023 worth over 15,450$. On average, Ms trades about 4,427 units every 0 days since 2023. As of 1 February 2023 she still owns at least 4,427 units of 908 Devices stock.
You can see the complete history of Ms Fitzpatrick stock trades at the bottom of the page.
Maura Fitzpatrick is the VP of Product Management & Marketing at 908 Devices.
Ms Fitzpatrick is 51, she's been the VP of Product Management & Marketing of 908 Devices since . There are 2 older and 3 younger executives at 908 Devices. The oldest executive at 908 Devices Inc. is Michael S. Turner Esq., J.D., 54, who is the VP, Sec. & Gen. Counsel.
Maura's mailing address filed with the SEC is C/O 908 DEVICES INC., 645 SUMMER STREET, BOSTON, MA, 02210.
Over the last 4 years, insiders at 908 Devices have traded over 16,182,689$ worth of 908 Devices stock and bought 826,585 units worth 15,798,345$ . The most active insiders traders include Keith Crandell、Kevin J. Knopp、E Kevin Hrusovsky. On average, 908 Devices executives and independent directors trade stock every 10 days with the average trade being worth of 64,663$. The most recent stock trade was executed by Christopher D. Brown on 7 August 2024, trading 6,328 units of MASS stock currently worth 9,998$.
908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry (Mass Spec) devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of gas, liquid, and solid materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. It operates in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company was incorporated in 2012 and is headquartered in Boston, Massachusetts.
908 Devices executives and other stock owners filed with the SEC include: